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INT ROD UCT ION
Prostaglandin (PG) D2 is a bioactive lipid mediator derived 
from arachidonic acid through the sequential reaction of cy-
clooxygenases (COXs) and PGD2 synthases (PGDSs; Ricci-
otti and FitzGerald, 2011). PGD2 exerts its functions through 
activation of D prostanoid receptors (DP1 and DP2; Joo and 
Sadikot, 2012). Recently, increasing evidence demonstrates 
that PGD2 is involved in resolution of inflammation (Buckley 
et al., 2014). For instance, a second increase in both COX-2 
expression and PGD2 production is observed at later stages 
(48 h) of carrageenan-induced inflammation, and treatment 
with COX-2 inhibitor exacerbates inflammation during 
resolution, which can be reversed by addition of exogenous 
PGD2 (Gilroy et al., 1999). Both PGD2 and PGE2 regulate 
and coordinate with lipoxins (LXs) to promote resolution of 
inflammation (Levy et al., 2001).Consistently, hematopoietic 
PGDS (H-PGDS) deficiency results in impaired inflamma-
tory resolution in mice (Rajakariar et al., 2007). However, 
the detailed molecular mechanisms of PGD2-mediated 
resolution remain unclear.
Macrophages play an important role in innate and adap-
tive immunity in response to exogenous pathogens, mediate 
inflammatory processes, and participate in the active resolution 
of inflammation by secreting antiinflammatory cytokines and 
eliminating dead cells and matrix debris (Headland and Nor-
ling, 2015). Plasticity and heterogeneity are the characteristic 
features of macrophages, which allow cells to undergo pheno-
typic shifts in response to different environmental signals. Two 
distinct subpopulations of macrophages are involved in recov-
ery after myocardial infarction (MI), a sterile inflammatory 
reaction (Nahrendorf et al., 2007; Yan et al., 2013). During 
this process, early responding macrophages (Ly6ChighCD-
The kinetic participation of macrophages is critical for inflammatory resolution and recovery from myocardial infarction (MI), 
particularly with respect to the transition from the M1 to the M2 phenotype; however, the underlying mechanisms are poorly 
understood. In this study, we found that the deletion of prostaglandin (PG) D2 receptor subtype 1 (DP1) in macrophages re-
tarded M2 polarization, antiinflammatory cytokine production, and resolution in different inflammatory models, including the 
MI model. DP1 deletion up-regulated proinflammatory genes expression via JAK2/STAT1 signaling in macrophages, whereas its 
activation facilitated binding of the separated PKA regulatory IIα subunit (PRK AR2A) to the transmembrane domain of IFN-γ 
receptor, suppressed JAK2–STAT1 axis–mediated M1 polarization, and promoted resolution. PRK AR2A deficiency attenuated 
DP1 activation–mediated M2 polarization and resolution of inflammation. Collectively, PGD2–DP1 axis–induced M2 polariza-
tion facilitates resolution of inflammation through the PRK AR2A-mediated suppression of JAK2/STAT1 signaling. These obser-
vations indicate that macrophage DP1 activation represents a promising strategy in the management of inflammation-associated 
diseases, including post-MI healing.
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11b+CD206−) predominate 1–3 d after MI and express high 
levels of M1 signature genes, such as TNF-α, IL-6, chemok-
ine C-C motif ligand 2 (CCL2), and nitric oxide synthase 2 
(NOS2), whereas late responders (Ly6ClowCD11b+CD206+) 
appear 4–7 d after MI and stimulate inflammatory resolution 
via the increased expression of M2-like reparative genes, in-
cluding IL-10, arginase 1 (arg1), and TGFβ1.
DP1 is highly expressed in monocytes/macrophages 
(Rajakariar et al., 2007; Sandig et al., 2007). Yet, the role of the 
PGD2–DP1 axis in the shaping of macrophage polarization 
and inflammatory resolution remains to be determined. In 
this study, we found that targeting DP1, but not DP2, resulted 
in a striking bias toward M1-like macrophage polarization 
in the presence of inducing stimuli. Moreover, the macro-
phage-specific genetic deletion of DP1 (DP1flox/floxLysMCre; 
termed macrophage-DP1 [Mac-DP1] KO) led to delayed 
resolution in multiple mouse models of inflammation. No-
tably, macrophage DP1 activation attenuated JAK2/STAT1 
signaling and accelerated resolution in a PKA regulatory IIα 
subunit (PRK AR2A)–dependent manner. Collectively, all 
the data suggest that DP1 activation–induced M2 polariza-
tion facilitates inflammatory resolution through the PRK 
AR2A-mediated suppression of JAK2/STAT1 signaling.
RES ULTS
Deletion of DP1 receptor, but not DP2, promotes M1 
macrophage polarization
Macrophage polarization is rapid and capable of dynamic in-
terconversion in response to environmental stimuli, as exem-
plified by induction of the M1 phenotype by LPS/IFN-γ and 
of the M2 phenotype by IL-4 (Sica et al., 2014). To assess the 
role of PGD2 in macrophage polarization, we first examined 
the expression of COXs, PGDSs, and DP receptors during 
macrophage polarization in vitro. Expression of COX-2 and 
H-PGDS (Fig.  1  A) and PGD2 production (not depicted) 
were markedly increased in response to LPS/IFN-γ, whereas 
IL-4 increased expression of DP1. Expression of DP2, in con-
trast, was down-regulated during both M1 and M2 polariza-
tion (Fig. 1 A). Interestingly, deletion of DP1 in macrophages 
attained with LysMCre mice (DP1flox/floxLysMCre; Mac-DP1 
KO; Fig. S1, A–C) and pharmacological inhibition of DP1 
(not depicted) markedly augmented M1 marker expression 
(Tnfa, Il1b, and Nos2) in response to LPS/IFN-γ stimula-
tion (Fig. 1 B) but suppressed M2 marker expression (Ym1, 
Arg1, and Mrc1) in response to IL-4 stimulation (DP1flox/
flox littermate; WT; Fig. 1 C). Similarly, we also observed that 
macrophage DP1 deficiency suppressed IL-4–induced M2 
polarization and promoted LPS/IFN-γ–mediated M1 polar-
ization by flow cytometry and immunostaining (Fig. 1, D–I). 
In contrast, DP1 reconstitution in DP1-deficient macro-
phages (Fig. 1 J) restrained M1 marker (Fig. 1, K and M) and 
enhanced M2 marker (Fig. 1, L and N) expression induced by 
LPS/IFN-γ and IL-4, respectively. However, we failed to de-
tect any significant effects of DP2 deficiency on macrophage 
polarization (not depicted). Collectively, these results indicate 
that the PGD2–DP1 axis directs macrophage polarization to-
ward an M2-like phenotype.
Mac-DP1 deletion delays resolution of inflammation by 
promoting M1 macrophage polarization in mice
An increase in PGD2 production in the later stages of a model 
of acute inflammation favors resolution of inflammation in 
mice (Gilroy et al., 1999). To address the role of DP1, we 
examined the dynamic alterations of macrophage proinflam-
matory and reparative genes expression with respect to the 
COX–PGDS–DP axis during the resolution of zymosan-in-
duced peritonitis. Consistent with a previous study (Gilroy 
et al., 1999), the second peak of COX-2 expression in peri-
toneal macrophages coincided with inflammatory resolution 
24 h after zymosan treatment (Fig. 2 A). COX-1 and lipo-
calin-type PGDS expression were also up-regulated, albeit at 
relatively low levels (Fig. 2 A). Similarly, macrophage PGD2 
production was increased at both 3 h and 24 h (Fig.  2 B), 
whereas DP1 expression inversely correlated with PGD2 pro-
duction (Fig. 2 C). Then, we examined the resolution indices 
(Bannenberg et al., 2005; Schwab et al., 2007) of PGD2 and 
DP1 agonist BW245C (BW) using a zymosan-induced peri-
tonitis model. As shown in Fig. 2 D, the resolution interval Ri 
of PGD2 and BW was shortened ∼2–3 h, and moreover, mac-
rophage resolution was also marked accelerated (not depicted). 
Moreover, DP1 disruption increased accumulation of perito-
neal leukocytes and macrophages at later stages of inflamma-
tion (Fig. 2, E and F). Flow cytometry analysis revealed that 
M1-like macrophages (F4/80+CD206−) were significantly 
increased, whereas M2-like macrophages (F4/80+CD206+) 
were decreased (Fig. 2, G and H) during resolution (24–72 h) 
in zymosan-treated Mac-DP1 KO mice as compared with 
DP1flox/flox littermates (WT). Consistent with these obser-
vations, all the tested proinflammatory genes (Tnfa, Mcp1, 
and Nos2 [Fig 2. I] and Il-6, Il-12β, Tlr2, Tlr4, Tlr9, and 
Ccr2 [not depicted]) were elevated, whereas the reparative 
genes (i.e., Ym1, Arg1, and Mrc1; Fig. 2  J) were depressed 
in DP1-deficient peritoneal macrophages. Immunofluores-
cence assays also revealed more M1-like residential macro-
phages (CD68+NOS2+) during resolution in Mac-DP1 KO 
mice than that in WT controls (not depicted). Furthermore, 
DP1 blockade by MK0524 24 h after zymosan challenge pro-
longed the resolution of inflammation (Fig. 2 K), promoted 
proinflammatory macrophage accumulation (Fig.  2 L), ele-
vated proinflammatory gene expression, and suppressed re-
parative gene expression (Fig. 2, M and N).
We also examined Escherichia coli infection–induced 
peritonitis in a cecal ligation and puncture (CLP) mouse 
model. During the resolution process, COX-1, H-PGDS, and 
DP1 mRNA expression in peritoneal macrophages and PGD2 
production were elevated (Fig.  3, A–C). However, macro-
phage-specific DP1 deletion exaggerated CLP-induced peri-
tonitis (Fig. 3 D), stimulated M1-like bias (Fig. 3 E), increased 
proinflammatory cytokine expression (Fig. 3, F and G), and, 
thus, reduced the overall survival rate of CLP (Fig. 3 H). Col-
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Figure 1. DP1 targeting promotes M1 macrophage polarization. (A) Expression of COXs, PGDSs, and PGD2 receptors in macrophages in response to 
LPS/IFN-γ and IL-4 treatment. L-PGDS, lipocalin PGDS. (B) Effect of DP1 deficiency on macrophage proinflammatory M1 marker expression in response 
to LPS/IFN-γ treatment. (C) Effect of DP1 deficiency on macrophage antiinflammatory M2 marker expression in response to IL-4 treatment. (A–C) *, P < 
0.05; **, P < 0.01 versus vehicle (A) or WT (B and C). n = 6. (D–F) Effect of DP1 deficiency on M1 (F4/80+CD206−) and M2 (F4/80+CD206+) macrophage 
distributions analyzed by flow cytometry. (D) Representative flow cytometry profiles. (E and F) Quantification of F4/80+CD206− (M1) and F4/80+CD206+ 
(M2) macrophages. (G–I) Effect of DP1 deficiency on M1 (CD68+NOS2+) and M2 (CD68+NOS2−) macrophage distributions analyzed by immunofluorescence. 
(G) Representative immunofluorescent images. Bar, 5 µm. (H and I) Quantification of M1 (CD68+NOS2+) and M2 (CD68+NOS2−) macrophages. (J–N) Effect 
of DP1 reconstitution on macrophage polarization. pc, pc-DNA3.1 vector. DP1 mRNA levels (J), NOS2 (K) and YM1 (L) mRNA levels, and protein levels (M 
and N) were examined in DP1-reexpressed DP1−/− macrophages. *, P < 0.05; **, P < 0.01 versus WT (D–F, H, and I) or vector (J–N). #, P < 0.05; ##, P < 0.01 
versus vehicle. n = 4. All graphs are shown as mean ± SEM. Data are representative of at least two independent experiments. Statistical significance was 
determined using unpaired Student's t tests.
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Figure 2. DP1 activation promotes timely resolution by triggering M2 polarization in zymosan-induced peritonitis in mice. (A–N) Peritoneal mac-
rophages were collected at the indicated time points after zymosan challenge. (A–C) COX and PGDS mRNA levels in peritoneal macrophages (A), PGD2 pro-
duction in peritoneal lavages (B), and DP1 expression in peritoneal macrophages (C) are shown. L-PGDS, lipocalin PGDS. (D) Resolution indices including Tmax 
(time point when PMNs reach maximal level),T50 (time point corresponding to ∼50% PMN reduction), and Ri (resolution interval, the interval between Tmax 
and T50) were calculated when 100 µg/kg PGD2 or 1 mg/kg BW was given at peak (12 h) of inflammation. For zymosan-induced inflammation: Tmax, ∼12 h; 
T50, ∼24h; Ri, ∼12 h. For plus PGD2: Tmax, ∼12 h; T50, ∼21 h; Ri, ∼9 h. For plus BW: Tmax, ∼12 h; T50, ∼22 h; Ri, ∼10 h. n = 4–6. (E–J) Total infiltrated leukocytes 
(E) and total macrophages (F), F4/80+CD206+ and F4/80+CD206− cells (G) and ratio (H), and mRNA levels of proinflammatory (I) and antiinflammatory (J) 
gene expression were analyzed from the initiation to resolution of zymosan-induced peritonitis in mice. (K–N) 4 mg/kg/day of DP1 antagonist MK0524 was 
administrated 24 h after zymosan challenge in mice, and peritoneal macrophages were collected at the indicated time points. Total macrophages (K) and 
F4/80+CD206+ and F4/80+CD206− cells (L) were calculated at different time points. Proinflammatory (M) and antiinflammatory (N) gene expression were 
examined in macrophages collected at 72 h after zymosan challenge. (E–J and K–N) *, P < 0.05; **, P < 0.01 versus WT (E–J) or vehicle (K–N). n = 4–6. All data 
are expressed as mean ± SEM. Statistical analysis was performed using unpaired Student’s t test. Data are representative of two independent experiments.
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lectively, these data suggest that the PGD2–DP1 axis directs 
macrophage polarization toward a reparative phenotype to 
promote inflammatory resolution.
Mac-DP1 deficiency impairs recovery from experimental MI 
by delaying resolution of inflammation
Monocytes/macrophages are involved in the healing process 
after MI, which involves proteolysis, phagocytosis, angiogene-
sis, and myocardial remodeling (Ben-Mordechai et al., 2015). In 
mice, reparative M2-like monocytes/macrophages (Ly-6Clow) 
predominate in the infarct zone during the resolution of in-
flammation (day 4–7 after MI) and propagate after MI recovery 
(Nahrendorf et al., 2007). Flow cytometry analysis (Fig. 4 A) 
revealed an accumulation of inflammatory cells (leukocytes and 
macrophages) in the hearts of Mac-DP1 KO mice 11 and 14 d 
after MI, when compared with control mice (Fig. 4, B and C). 
Interestingly, infiltrating M1-like macrophages (CD68+D206−) 
appeared more frequently, whereas M2-like macrophages 
(CD68+D206+) were reduced at days 11 and 14 after MI in 
Mac-DP1 KO hearts compared with those from WTs (Fig. 4, 
D–G), consistent with marker gene expression (Fig. 4, H and 
I). Both functional recovery (Fig. 4 J) and the extent of tissue 
damage after MI (Fig. 4, K and L) were markedly altered in 
Mac-DP1 KO mice consistent with delayed healing caused by 
disruption of M2-dependent resolution of inflammation.
DP1-mediated inflammation resolution is dependent on 
JAK2/STAT1 activity in macrophages
It has been proposed that STAT1 activation is indispensable 
for M1 macrophage polarization, whereas M2 macrophage 
differentiation requires STAT6 activity (Sica and Mantovani, 
2012). The DP1 agonist BW inhibited JAK2 and STAT1 
phosphorylation in response to IFN-γ treatment but had no 
influence on that of JAK1 and JAK3. In contrast, DP1 ac-
tivation augmented IL-4–induced STAT6 phosphorylation 
(Fig. 5 A). Consistently, BW pretreatment suppressed IFN-γ–
induced NOS2 expression but enhanced IL-4–induced YM1 
expression (Fig.  5  B). Moreover, DP1 disruption amplified 
JAK2 and STAT1 phosphorylation (Fig. 5 C) and attenuated 
IL-4–mediated STAT6 activation in macrophages (Fig. 5 D) 
without overt effects on JAK1 and JAK3 phosphorylation. 
We then examined whether excessive JAK2–STAT1 pathway 
activation contributed to M1 bias in DP1-deficient macro-
phages. As shown in Fig. 5 (E–H), the JAK2 specific inhibitor 
CEP33791(CEP) completely inhibited STAT1 activation, at-
tenuated M1 gene expression, and rescued STAT6 phosphor-
ylation and M2 marker gene expression in DP1-deficient 
macrophages. Likewise, the STAT1 inhibitor Fludara (FLU) 
also attenuated excessive STAT1 activity and M1 gene expres-
sion and rescued M2 gene expression in DP1-deficient mac-
rophages (Fig. 5, I–L). Moreover, increased JAK2 and STAT1 
phosphorylation and decreased STAT6 phosphorylation were 
also observed in Mac-DP1 KO peritoneal macrophages har-
vested after zymosan treatment (Fig. 5 M). Collectively, these 
observations are consistent with PGD2–DP1 axis promotion 
of M2 polarization via modulation of JAK2/STAT1 signaling.
Because loss of DP1 represses M2 macrophage polar-
ization by activating JAK2/STAT1 signaling, retarding reso-
lution of inflammation, we next examined whether STAT1 
inhibitor treatment could rescue delayed resolution in vivo. 
Figure 3. DP1 deficiency aggravates in-
flammation and mortality in a CLP mouse 
model. (A–E) Peritoneal macrophages were 
sorted at different post-CLP time points and 
subjected to mRNA expression analysis of 
COXs and PGDSs (A) and DP1 (B). L-PGDS, lipo-
calin PGDS. (C) PGD2 production in peritoneal 
lavage fluid was also measured. (D and E) Total 
macrophages (D) and ratio of F4/80+CD206+ 
and F4/80+CD206− cells (E) were calculated. n 
= 4–6. (F and G) mRNA levels of proinflamma-
tory genes and antiinflammatory genes were 
examined in peritoneal macrophages sorted 
72  h after CLP in mice. n = 6. (H) Effect of 
macrophage DP1 deficiency on survival rates 
of mice with CLP-induced sepsis. n = 15. *, P < 
0.05; **, P < 0.01 versus WT. Graphs are shown 
as mean ± SEM. Results are representative of 
two independent experiments. (D–G) Statis-
tical significance was determined using un-
paired Student's t tests. (H) Survival rate was 
compared using the log-rank test.
o
n
 O
ctober 30, 2016
D
ow
nloaded from
 
Published September 12, 2016
PRK AR2A mediates PGD2-induced resolution | Kong et al.2214
Again, Mac-DP1 deletion postponed inflammatory resolu-
tion (increase of total inflammatory cells and macrophages 
at both 48 h and 72 h), and this was restored by STAT1 in-
hibition (Fig.  5, N and O). Likewise, the STAT1 inhibitor 
corrected the reduction in M2-like macrophages and elevated 
proinflammatory and attenuated antiinflammatory gene ex-
pression in Mac-DP1 KO mice at both 48 and 72 h (Fig. 5, 
P–R). Thus, the STAT1 inhibitor could rescue impaired res-
olution in Mac-DP1 KO mice by rectifying macrophage 
polarization in the zymosan-induced peritonitis model. 
Moreover, in experimental MI, an example of sterile inflam-
mation, STAT1 inhibition suppressed infiltration of M1-like 
macrophages (Fig.  6, A–D), corrected the M1 polarization 
bias (Fig. 6, E and F), and blunted the prolonged retention 
of infiltrating leukocytes and macrophages in Mac-DP1 KO 
mice (Fig. 6, G and H), resulting in restoration of myocar-
dial function (Fig. 6 I).
DP1 activation facilitates PRK AR2A–IFN-γR2 binding to 
suppress JAK2/STAT1 signaling in macrophages
The DP1 receptor couples to Gs to trigger cyclic adenosine 
monophosphate (cAMP)/PKA-dependent cellular functions 
(Breyer et al., 2001). As anticipated, DP1 activation increased 
intracellular cAMP levels, whereas its ablation markedly re-
duced cAMP generation (Fig.  7  A). To evaluate whether 
DP1-mediated M2 macrophage polarization is cAMP/PKA 
dependent, Rp-cAMP and H89, which inhibit PKA regula-
tory and catalytic subunit dissociation and its kinase activity, 
respectively, were used to treat macrophages cultured in the 
presence of M1-polarizing stimuli. Notably, the DP1 agonist 
BW and adenylyl cyclase activator Forskolin both inhibited 
JAK2/STAT1 activation, which was attenuated by Rp-cAMP 
but not H89 (Fig. 7 B). Moreover, Rp-cAMPs rescued JAK2/
STAT1 activity, reduced M1 marker expression, and aug-
mented M2 marker expression in BW-treated macrophages in 
Figure 4. DP1 deletion in macrophages 
impairs MI healing by suppressing M2 po-
larization and resolution in ischemic hearts. 
(A–G) Effect of DP1 deficiency in macrophages 
on inflammatory resolution during post-MI 
recovery. (A) Inflammatory cell infiltrate in 
infarcted hearts was isolated from both WT 
and Mac-DP1 KO mice. (B–G) Total CD45+ leu-
kocytes (B), CD45+CD11b+ F4/80+Ly6G− mac-
rophages (C), and F4/80+CD206− and F4/80+ 
CD206+ cells (D and E) and their ratios (F and 
G) were calculated at different time points. n = 
4–6. (H and I) Effect of DP1 deletion on mRNA 
expression of proinflammatory genes (H) and 
antiinflammatory genes (I) in macrophages 
infiltrated in hearts. n = 6. (J and K) Effect of 
DP1 deficiency in macrophages on post-MI 
recovery in mice. (J) The ejection fraction was 
evaluated by echocardiography. Pre, pre-liga-
tion. n = 10–14 per group. (K) Infarct areas 
were analyzed at day 14 by Evans blue dye 
and tetrazolium chloride staining, followed by 
OPT IMAS software analysis for color enhance-
ment. Dotted lines denote the infarct zone. The 
darkest area is normal heart tissue, whereas 
the gray area represents at-risk myocardial 
tissue. Bar,10 mm. (L) Quantitation of infarcted 
areas. n = 6. *, P < 0.05; **, P < 0.01 versus WT. 
Representative data are shown as mean ± SEM 
derived from two independent experiments. 
Statistical significance was determined using 
unpaired Student's t tests.
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Figure 5. DP1 disruption suppresses M2 polarization and postpones resolution through JAK2/STAT1 pathway activation. (A and B) DP1 agonist 
(BW)–treated macrophages were analyzed for IFN-γ–induced JAK2/STAT1 phosphorylation (A) and NOS2 expression (B). (C and D) DP1 KO macrophages 
were examined for IFN-γ–induced JAK2/STAT1 phosphorylation (C) and IL-4–induced STAT6 phosphorylation (D). (E–H) DP1-deficient and WT macrophages 
were pretreated with JAK2 inhibitor CEP and monitored for JAK2/STAT1 phosphorylation (E), proinflammatory gene expression (F), STAT6 phosphoryla-
tion (G), and antiinflammatory gene expression (H). *, P < 0.05; **, P < 0.01 versus WT. #, P < 0.05 versus without CEP. n = 4. (I–L) DP1-deficient and WT 
macrophages were pretreated with the STAT1 inhibitor FLU and assessed for JAK2/STAT1 phosphorylation (I), proinflammatory gene expression (J), STAT6 
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a dose-dependent manner (Fig. 7, C–E), whereas H89 had no 
significant effect on DP1-mediated M2 polarization (not de-
picted). Conversely macrophage-specific DP1 overexpression 
(Mac-DP1 Tg; two lines with >20-fold increase of DP1 ex-
pression in macrophages; Fig. S2, A–C) promoted the resolu-
tion of zymosan-induced peritonitis by inhibiting leukocyte 
and macrophage infiltration, suppressing proinflammatory 
genes expression, and enhancing reparative marker expression 
(Fig. 7, F–J). These phenomena were specifically attenuated 
by Rp-cAMP treatment (Fig.  7, F-J). Thus, DP1-mediated 
M2 polarization and JAK2/STAT1 depression relies on the 
dissociation of the PKA regulatory and catalytic subunits, 
rather than PKA catalytic activity.
JAK activity can be regulated either by intrinsic regula-
tory elements, such as its transphosphorylation and inhibitory 
pseudokinase domain, or by direct binding of extrinsic neg-
ative modulators, including suppressor of cytokine signaling 
(SOCS) family members and SH2B3 (Babon et al., 2014). We 
then examined whether PKA subunits may modulate JAK2 
activity through direct interactions with JAK2 or IFN-γR2. 
Interestingly, we did not find any PKA subunits in the an-
ti-JAK2 immunoprecipitate, whereas PRK AR2A protein was 
discovered in that of anti–IFN-γR2 (Fig. 7 K). Subsequently, 
we confirmed this interaction in an exogenous overexpres-
sion system with FLAG-tagged IFN-γR2 and hemaggluti-
nin (HA)-tagged PRK AR2A in RAW264.7 macrophages 
(Fig. 7, L and M), as well as by Western blotting in 293T cells 
(Fig. 7, N and O). DP1 activation increased the membrane 
mobilization of free PRK AR2A in macrophages, as well as 
its colocalization with IFN-γR2, whereas this was markedly 
decreased in Mac-DP1 KO macrophages (Fig. 7, P and Q). 
Consistent with these observations, BW augmented the PRK 
AR2A–IFN-γR2 interaction (Fig. 7 R), which was blunted 
by Rp-cAMP in a dose-dependent manner (Fig. 7 S). These 
results indicate that PRK AR2A dissociation and the subse-
quent binding of IFN-γR2 may contribute to DP1-mediated 
M2 polarization. Thus, DP1-facilitated M2 polarization ap-
pears to be contingent on the PRK AR2A–IFN-γR2 interac-
tion–mediated suppression of JAK2/STAT1 signaling.
Truncated protein pull-down assays in 293T cells indi-
cated that PRK AR2A binds the IFN-γR2 transmembrane 
region (TMR) through its phosphate-binding cassette (PBC) 
domain (Fig. 8, A–D), which was confirmed by in vitro bind-
ing assays with recombinant purified protein (Fig. 8, E–H). 
Consistent with this observation, overexpression of the TMR 
fragment in macrophages blocked DP1-mediated JAK2/
STAT1 suppression, STAT6 activation, and M2 polarization 
(Fig. 8, I–L). Thus, this evidence supports the contention that 
DP1 activation facilitates binding between the PRK AR2A 
PBC and the IFN-γR2 TMR domains to suppress JAK2/
STAT1 signaling–mediated M1 macrophage polarization.
PRK AR2A disruption abolishes PGD2–DP1 axis–induced M2 
macrophage polarization and resolution of inflammation
Both PRK AR2A and PRK AR1A were the most abun-
dant of the four PKA regulatory isoforms in macrophages, 
although they have little homology in their PBC domains 
(Fig. 9 A). Interestingly, Prkar2a was up-regulated upon M2 
polarization (Fig. 9 B). PRK AR2A deletion (Fig. 9 C; Sa-
loustros et al., 2015) resulted in JAK2/STAT1 activation and 
M1 polarization in macrophages (Fig. 9, D and E). BW sup-
pressed JAK2/STAT1 activation and M1 polarization, which 
was entirely abolished by deletion of PRK AR2A (Fig.  9, 
D and E). Interestingly, Prkar1a was up-regulated in PRK 
AR2A-deleted macrophages (Fig. 9 C). Then, we explored 
the role of PRK AR2A deficiency on DP1 activation–medi-
ated resolution. As expected, DP1 agonist BW significantly 
accelerated the resolution of zymosan-induced peritonitis by 
inhibiting leukocyte and macrophage infiltration, suppressing 
proinflammatory genes expression, and enhancing reparative 
markers expression (Fig. 9, F–J). Strikingly, PRK AR2A de-
ficiency attenuated BW-induced M2 polarization and reso-
lution of inflammation (Fig.  9, G–K), whereas knockdown 
of Prkar1a had no effect on macrophage polarization (Fig. 10, 
A–G). Collectively, PRK AR2A–IFN-γR2 interaction in 
macrophages is required for PGD2–DP1 axis–mediated res-
olution of inflammation.
DIS CUS SION
Monocyte/macrophage infiltration is critical for inflam-
matory resolution (Serhan et al., 2007) and MI recovery 
(Ben-Mordechai et al., 2015). Here, we observed enhanced 
COX-2 and DP1 expression as well as PGD2 biosynthesis 
in macrophages during inflammatory resolution. Disruption 
of the DP1 receptor in macrophages postponed inflamma-
tory resolution in multiple peritonitis models, promoting 
M1 polarization, and thus increased CLP-induced peritonitis 
mortality and impaired MI healing. DP1 deficiency also en-
hanced JAK2/STAT1 transcriptional activity in macrophages 
by suppressing PKA complex disaggregation and subsequent 
binding of the PRK AR2A to the IFN-γ receptor. These ob-
servations indicate that macrophage DP1 activation represents 
phosphorylation (K), and antiinflammatory gene expression (L). *, P < 0.05; **, P < 0.01 versus WT. #, P < 0.05; ##, P < 0.01 vs. without FLU. n = 4. (M) Sorted 
peritoneal macrophages harvested after zymosan treatment in WT and DP1-deficient mice were assessed for JAK2/STAT1/STAT6 phosphorylation. (N–R) 40 
mg/kg/12 h of FLU was administered 24 h after zymosan challenge in WT and Mac-DP1 KO mice. Peritoneal cells were then collected at the indicated time 
points. Total infiltrated cells (N), total CD11b+F4/80+ cells (O), M2 ratio (P), M1 genes expression (Q), and M2 genes expression (R) of macrophages from 
Mac-DP1 KO mice at resolution phase are shown. *, P < 0.05; **, P < 0.01 as indicated. #, P < 0.05 versus without FLU. n = 4. Data are expressed as mean ± 
SEM. Statistical analysis was performed using two-way ANO VA followed by a Bonferroni posthoc test (N–P) or unpaired Student’s t test (F, H, J, L, Q, and R). 
All Western blots were repeated three times, and the others were also verified in two independent experiments.
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a promising strategy in the management of inflammation-as-
sociated diseases, including post-MI healing.
In a rodent model of carrageenin-induced pleurisy, 
PGD2 is reported to be produced both in the initiation phase 
and in the resolution phase (biphasic; Gilroy et al., 1999). 
COX-2 inhibitors aggravate the carrageenin-induced inflam-
mation at the later stage. This aggravation is associated with 
reduced PGD2 and 15-d PGJ2 and can be relieved by replace-
ment of these PGs (Gilroy et al., 1999). Consistently, we ob-
served both PGD2 and DP1 receptor agonist BW accelerate 
resolution in a zymosan-induced peritonitis mouse model. In 
addition, COX-2–derived LXA4 and 15-epi-LXA4 (in the 
presence of aspirin) contribute to the resolution of acute lung 
injury (Fukunaga et al., 2005). Along with LXA4, COX-2–
derived PGE2 appears to promote the resolution of allergic 
pleuritis in rats (Bandeira-Melo et al., 2000).
Plasticity and heterogeneity are key features of mac-
rophages. In tissues, macrophages embrace diverse func-
tional phenotypes in response to environmental cues (Sica 
and Mantovani, 2012). IFNs and TLR ligands activate tra-
ditional IFN regulatory factor/STAT1 signaling pathways to 
drive macrophages toward a classic M1 phenotype, whereas 
IL-4 and IL-13 induce STAT6 activation to skew macro-
phages to an alternative M2 phenotype. Moreover, IL-10 can 
markedly suppress LPS-induced transcription and enhance 
antiinflammatory gene expression to direct macrophages to 
an M2 phenotype via STAT3 signaling (Lang et al., 2002). 
STAT1 (via IFNs) and STAT6 activation in macrophages 
also facilitates expression of SOCS1 (Whyte et al., 2011) and 
SOCS3 (Liu et al., 2008), which in turn restrain STAT6 and 
STAT1 activity, respectively. Furthermore, the DP1 agonist 
suppressed JAK2 and STAT1 phosphorylation, also increasing 
that of STAT6 in macrophages. In contrast, Mac-DP1 dis-
ruption led to enhanced JAK2/STAT1 activity and repressed 
STAT6 activity without any significant influence on STAT3 
signaling. Therefore, DP1 deficiency promoted macrophage 
Figure 6. FLU treatment attenuates exacerbated LAD ligation–induced inflammation and heart failure caused by macrophage-DP1 deletion in 
mice. (A–D) 40 mg/kg FLU twice daily was administrated to mice at day 4 after LAD ligation. Infiltrating macrophages isolated from infarcted hearts were 
sorted to calculate F4/80+CD206− and F4/80+CD206+ macrophages and ratios at the indicated time points. (E and F) mRNA levels of proinflammatory (E) 
and antiinflammatory (F) genes were examined in macrophages harvested at day 14. *, P < 0.05 versus WT. #, P < 0.05 versus without FLU. n = 6. (G and 
H) Total CD45+ leukocytes (G) and macrophages (H) per heart were also compared. *, P < 0.05 as indicated. n = 5–6. (I) Effect of FLU on heart function in 
Mac-DP1 KO and WT mice after LAD ligation. *, P < 0.05. n = 10–12. LVEF, left ventricular ejection fraction. All data are expressed as mean ± SEM. P-values 
were calculated using two-way ANO VA followed by a Bonferroni posthoc test (A–D and G–I) or unpaired Student’s t test (E and F).
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M1 polarization by disturbing the balance between STAT1 
and STAT6/STAT3 pathways.
DP1 activation–induced JAK2/STAT1 suppression was 
interrupted by Rp-cAMP, but not H89, suggesting that JAK2/
STAT1 signaling was modulated by PKA subunit dissociation 
rather than its own kinase activity. PKA is a holoenzyme 
comprised of two regulatory (R) and two catalytic (C) subunits. 
Multiple isoforms have been identified for R (RIα, RIβ, RIIα, 
and RIIβ) and C (Cα, Cβ, and Cγ) subunits (Taylor et al., 
2013). Through various approaches, only RIIα was identified 
to bind directly the IFN-γR2 TMR domain through its PBC 
domain, and blocking this binding attenuated PGD2–DP1 
axis–mediated JAK2/STAT1 inhibition and M2 polarization. 
Consistently, only RIIα expression was up-regulated in M2 
macrophages. With respect to the cAMP docking site, the 
RIIα PBC domain does not share structural homology with 
other R subunits (Su et al., 1995). Generally, R units mediate 
PKA compartmentalization through their physical binding to 
A-kinase anchoring proteins (AKAPs) in different subcellular 
compartments (Skroblin et al., 2010). Indeed, several AKAPs, 
such as AKAP-2, AKAP-4, and MEKK (also known as 
MAP3K1, short for mitogen-activated protein kinase kinase 
kinase 1), also coimmunoprecipitated with FLAG-PRK 
AR2A in macrophages. Besides regulating PKA activity, PKA 
R units also directly participate in many biological processes 
(Filteau et al., 2015), including transcriptional co-repression 
(Elliott et al., 2003) and calcium signal modulation (Manni 
et al., 2008). Normally, the hydrophobic cluster in the PBC 
domain of PKA R units binds to an extensive hydrophobic 
surface that surrounds Tyr247 in the G helix of PKA C 
units (Wu et al., 2007). Upon stresses, cAMP incorporates 
the PBC domain of PKA R units, which leads to stretch 
away of PKA C units and facilitates PBC domain binding to 
other hydrophobic proteins, such as the IFN-γR2 receptor. 
In an M1-prone state, JAK2 phosphorylation is triggered 
by IFN-γ binding to its cognate receptor dimer (IFN -γR2 
:IFN -γR1), which elicits conformational change of IFN-γ 
receptor dimer and repositioning of the associated JAK2 
and ultimately transphosphorylation of a tyrosine residue 
in the conserved activation loop of JAK2 (Babon et al., 
2014). Thus, we deduce that the enhanced binding of PRK 
AR2A to IFN-γR2 by DP1 activation may stabilize IFN-γ 
receptor dimerization within the macrophage membrane, 
thereby inhibiting IFN-γ–induced conformation changes 
of IFN -γR2 :IFN -γR1 dimer and JAK2/STAT1 activation 
during M2 polarization. Likewise, this PKA-dependent 
suppression of IFN-induced JAK/STAT activity was also 
observed in Ehrlichia chaffeensis–infected THP-1 human 
monocytes and U266 myeloma cells (David et al., 1996; 
Lee and Rikihisa, 1998). Consistent with these observations, 
PGD2 induces 15-lypoxygenase expression and generation 
of pro-resolution LXA4 in polymorphonuclear neutrophils 
dependent on intracellular cAMP accumulation (Levy et 
al., 2001), perhaps through activation of a Gs-coupled DP1 
receptor (Breyer et al., 2001).
Cardiac healing after MI requires a balanced inflamma-
tory response. Macrophages are the dominant cells orches-
trating the initiation, amplification, and resolution of the 
inflammation in the infracted myocardium (Ben-Mordechai 
et al., 2015). Proinflammatory M1 macrophages are recruited 
shortly after neutrophils, peaking around day 3 after MI, and 
display phagocytic and proteolytic functions, whereas antiin-
flammatory M2 macrophages accumulate at later points and 
facilitate tissue repair by secreting angiogenic, trophic, and 
profibrotic cytokines (Nahrendorf et al., 2007; Ben-Morde-
chai et al., 2013). We observed that DP1 targeting promoted 
proinflammatory monocyte recruitment and suppressed that 
of reparative monocytes, resulting in prolonged resolution 
during MI recovery in mice. Monocytes/macrophages reside 
within the infarcted heart for relatively short periods (∼20 h), 
with most (<95%) undergoing apoptosis (Leuschner et al., 
2012). Interestingly, DP1 ablation did not alter the apoptosis 
of infiltrated macrophages but inhibited M2 polarization and 
antiinflammatory cytokine expression both in vitro and in 
vivo. Thus, DP1-mediated M2 polarization contributes to MI 
recovery by promoting timely resolution of inflammation.
In summary, DP1 activation in macrophages promotes 
M2 polarization and timely inflammatory resolution through 
the PKA regulatory unit–mediated suppression of JAK2/
STAT1 signaling. These observations indicate that targeting 
the PGD2–DP1 pathway may represent a promising thera-
peutic strategy for inflammatory disease.
Figure 7. DP1 activation facilitates PRK AR2A–IFN-γR2 binding to suppress macrophage JAK2/STAT1 signaling. (A) WT and DP1-deficient mac-
rophages were treated with DP1 agonist and monitored for changes in intracellular cAMP levels. *, P < 0.05 versus WT. ##, P < 0.01. n = 6. FOS, Forskolin. 
(B) Effect of Rp-cAMP (RP) and H89 on Forskolin-mediated suppression of JAK2/STAT1 phosphorylation in macrophages. (C–E) Effect of Rp-cAMP (10 µM, 
50 µM, and 100 µM) on BW-mediated JAK2/STAT1 phosphorylation (C), M1 gene expression (D), and M2 gene expression (E) in macrophages. *, P < 0.05; **, 
P < 0.01 as indicated. n = 4. (F–J) Rp-cAMP was administrated 24 h after zymosan challenge in Mac-DP1 transgenic (Tg) mice. Peritoneal cells were collected 
to monitor CD45+ cells (F), total CD11b+F4/80+ cells (G), M2 percentage (H), and M1 (I) and M2 (J) gene expression. *, P < 0.05; **, P < 0.01 as indicated. n 
= 4–6. (K) Representative silver staining of anti–IFN-γR2 (IFN GR2) immunoprecipitate (IP). The marked proteins were resulted from LC-MS/MS. (L–O) The 
IFN-γR2–PRK AR2A interaction was analyzed by anti-FLAG (L and N) and anti-HA (M and O) immunoprecipitation. (P and Q) Effect of BW treatment on 
PRK AR2A and IFN-γR2 colocalization in macrophages (P) and quantification (Q). *, P < 0.05 versus WT. ##, P < 0.01 versus without BW. n = 4. Bar, 5 µm. 
Arrowheads indicate colocalization of PRK AR2A and IFN-γR2 in the membrane. (R) Analysis of the IFN-γR2–PRK AR2A interaction in BW-treated WT and 
Mac-DP1 KO macrophages. (S) Effect of Rp-cAMP (10 µM, 50 µM, and 100 µM) on the BW-induced IFN-γR2–PRK AR2A interaction in macrophages. Data 
are presented as mean ± SEM and are representative of at least two independent experiments. Statistical analysis was performed using a two-way ANO VA 
followed by a Bonferroni posthoc test (F–H) or unpaired Student’s t test (A, D, E, I, J, and Q).
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Figure 8. PRK AR2A binding to the IFN-γR2 TMR is required for the DP1-mediated suppression of JAK2/STAT1 signaling and M2 polarization in 
macrophages. (A) FLAG–IFN-γR2 was cotransfected with HA-PRK AR2A–truncated mutants into 293T cell. D/D, dimerization/docking domain; IS, inhibitor 
site domain. (B) Immunoprecipitation (IP) assays were performed with FLAG antibody, and Western blot analysis was conducted with HA antibody. IFN GR2, 
IFN-γGR2. (C) HA-PRK AR2A was cotransfected with FLAG−IFN-γR2–truncated mutants into 293T cells. (D) Immunoprecipitation assays were performed 
with HA antibody, and Western blot analysis was conducted using FLAG antibody. (E–H) GST and His pulldown assays were used to examine direct interac-
tions of purified IFN-γR2 with PRK AR2A, including full-length proteins (E and F) and the TMR fragment of IFN-γR2 with PBC fragment of PRK AR2A (G and 
H). (I–L) Effect of IFN-γR2 TMR domain overexpression on BW-induced suppression of JAK2/STAT1 activity (I), STAT6 phosphorylation (J), proinflammatory 
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Animals
DP1flox/flox mice, possessing two loxP sites flanking exon 1 
of the DP1 gene (Fig. S1 A; provided by R. Breyer, Vander-
bilt University Medical Center, Nashville, TN), were main-
tained on C57BL/6 genetic background and crossed with 
C57BL/6 LysMCre mice to generate DP1flox/floxLysMCre 
(Mac-DP1 KO) mice. DP1flox/flox littermates (WT) served as 
experimental controls. Macrophage-specific DP1 transgenic 
(Mac-DP1 Tg) mice were generated by Caygen Biosciences 
on the C57BL/6 genetic background using macrophage-spe-
cific synthetic promoter 146 (SP146; Kang et al., 2014). PRK 
AR2A−/− mice were maintained on C57BL/6 genetic back-
ground. All WT littermates were used as experimental con-
trols. All animals were maintained and used in accordance 
with the guidelines of the Institutional Animal Care and Use 
Committee of the Institute for Nutritional Sciences, Univer-
sity of Chinese Academy of Sciences.
Reagents
IFN-γ and IL-4 were from PeproTech. LPS, zymosan, thio-
glycolate, IBMX, and the ProteoSilver Plus Stain kit were 
from Sigma-Aldrich. PGD2, H89, and BW245C were from 
Cayman Chemical. Forskolin was obtained from Enzo Life 
Sciences. FLU and CEP33791 were from Selleck Chemical. 
MK0524 was from Santa Cruz Biotechnology, Inc.
Peritoneal macrophage isolation and treatment
Peritoneal macrophages were induced and prepared by an i.p. 
injection of 3% Brewer’s thioglycolate as described previously 
(Yang et al., 2010). Macrophages were allowed to adhere 
overnight at 37°C and 5% CO2 and were washed with fresh 
medium to remove unattached cells before use. Adherent 
macrophages were pretreated with 1 µM BW245C, 0.1 mM 
CEP33791, 100 µM FLU, or 10 µM H89 2 h before stim-
ulation. Macrophage polarization was subsequently induced 
with 1 µg/ml LPS plus 20 ng/ml IFN-γ or IL-4 and analyzed 
with real-time PCR (RT-PCR; all primers used in this study 
are described in Table S1).
Zymosan-induced peritonitis model
1 mg type A zymosan in 0.5 ml PBS (Sigma-Aldrich) was 
injected to the peritoneal cavity to induce peritonitis in 
mice (Rajakariar et al., 2007). 40 mg/kg FLU was then ad-
ministrated as indicated. Peritoneal inflammatory cells were 
obtained by using 8 ml of sterile PBS to wash out the in-
flamed peritoneal cavity at progressive time points. The cells 
were then collected by centrifugation at 800  g for 5 min, 
and supernatants were stored at −80°C until PG analysis. Pel-
leted cells were counted with a hemocytometer (02270113; 
QIU JING) and stained with antibodies for flow cytometry. 
Macrophages were also sorted at the different time points to 
examine intracellular cAMP levels and M1/M2 gene expres-
sion, as well as JAK2, STAT1, and STAT6 phosphorylation.
Resolution indices of peritonitis model
Resolution indices were calculated as previously described 
(Bannenberg et al., 2005; Schwab et al., 2007). 100 µg/kg 
PGD2 or 1mg/kg BW was given at peak (12 h) of zymo-
san-induced inflammation. After 12 h, peritoneal inflamma-
tory cells were obtained by using 8 ml of sterile PBS to wash 
out the inflamed peritoneal cavity. The cells were then col-
lected by centrifugation at 800 g for 5 min. Pelleted cells were 
counted with a hemocytometer and stained with antibodies 
(PE-conjugated anti–mouse CD45 antibody and APC-con-
jugated anti–mouse Ly6G antibody) for flow cytometry.
CLP mouse model
CLP surgeries were performed on 2-mo-old female mice as 
previously described (Hubbard et al., 2005; Ishii et al., 2012). 
Peritoneal lavage fluid was collected at different time points 
after CLP surgery and centrifuged at 800 g for 5 min at 4°C, 
and the supernatants were stored at −80°C until PG analysis. 
Pelleted peritoneal inflammatory cells were counted with a 
hemocytometer and stained with specific antibodies for flow 
cytometry. Sorted macrophages were subjected to quantita-
tive RT-PCR (qRT-PCR) analysis to examine the mRNA 
expression of different genes. For survival studies, cecal were 
punctured five times with a 21-gauge needle after ligation.
MI mouse model
Female, 6–8-wk-old mice were subjected to a permanent li-
gation of the left anterior descending (LAD) coronary (Gao et 
al., 2010). In brief, mice were fully anesthetized with 1–1.5% 
isoflurane gas before being mechanically ventilated with a 
rodent respirator. The chest cavity was opened via left thora-
cotomy to expose the heart so that LAD could be visualized 
and permanently ligated with a 6–0 silk suture at the site of 
its emergence from the left atrium. Complete vessel occlusion 
was confirmed by the presence of myocardial blanching in 
the perfusion bed. Mice that died within 24 h after surgery 
were excluded from the experiment. Sham-operated animals 
underwent the same procedure without coronary artery liga-
tion. Mice were later euthanized at different time points to 
analyze immune cell infiltration.
Cell sorting from post-MI hearts
Female, 6–8-wk-old mice were anesthetized and intra-
cardially perfused with 40  ml of ice-cold PBS to exclude 
blood cells. The heart was dissected, minced with fine scis-
gene expression (K), and antiinflammatory gene expression (L) in macrophages. *, P < 0.05; **, P < 0.01 as indicated. n = 4. Data are presented as mean ± 
SEM. (A–J) Data are representative of two independent experiments. (K and L) Data are repeated three times, and statistical significance was determined 
using unpaired Student's t tests.
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Figure 9. PRK AR2A deficiency attenuates BW245C-induced M2 polarization and resolution of inflammation in mice. (A) PBC domain of four PKA 
R subunits (RIα, RIβ, RIIα, and RIIβ). (B) Prkar1a and Prkar2a expression in macrophages in response to LPS/IFN-γ and IL-4 treatment. **, P < 0.01. n = 6. (C) 
Prkar1a and Prkar2a expression in Prkar2a−/− macrophages. (D and E) Effect of Prkar2a deletion on STAT6 (D) and JAK2/STAT1 activity (E) in BW-pretreated 
macrophages. (F–J) BW was administrated 24 h after zymosan challenge in PRK AR2A−/− mice. Peritoneal inflammatory cells were collected to monitor 
CD45+ cells (F), total CD11b+F4/80+ cells (G), M2 ratio (H), and M1 (I) and M2 (J) gene expression. *, P < 0.05; **, P < 0.01 as indicated. #, P < 0.05 versus 
vehicle. n = 4–6. (K) Schematic of PGD2–DP1 axis–mediated JAK2/STAT1 inhibition and M2 polarization. IFN GR, IFN-γR; RP, Rp-cAMP. Data are presented as 
mean ± SEM. Statistical analysis was performed using two-way ANO VA followed by a Bonferroni posthoc test (F–H) or unpaired Student’s t test (B, I, and 
J). All Western blots were repeated for three times, and the others were also verified in two independent experiments.
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sors, and enzymatically digested with a cocktail of 450 U/
ml collagenase I, 125 U/ml collagenase XI, 60 U/ml DNase 
I, and 60 U/ml hyaluronidase (Sigma-Aldrich) for 1.5 h at 
37°C with gentle agitation. After digestion, the tissue was 
triturated and passed through a 70-µm cell strainer. Leu-
kocyte-enriched fractions were isolated by 37–70% Percoll 
(GE Healthcare) density gradient centrifugation as described 
previously (Yan et al., 2013). Cells were removed from the 
interface and washed with RPMI 1640 cell culture me-
dium before staining with CD45 and CD11b and sorting 
into three populations: CD45+CD11b+ (myeloid cells), 
CD45+CD11blow (lymphocytes), and CD45−CD11blow 
(nonleukocytes). The CD45+CD11b+ population could 
be further divided into CD11b+F4/80+ macrophages and 
CD11b+Ly-6G+ neutrophils.
Infarct size evaluation
To evaluate infarct size after MI, 0.2 ml of 2% Evans blue dye 
was injected into the tail vain, and then, hearts were removed 
and frozen at −80°C. The frozen heart was then cut trans-
versely into 1-mm thick slices using a Mouse Heart Slicer 
Matrix (Leica Biosystems) and stained with 2% tetrazolium 
chloride in PBS (pH 7.4) for 20 min in a 37°C water bath. 
After fixation for 4–6 h in 10% neutral buffered formalde-
hyde, each slice was weighed and photographed. Infarct areas 
were measured by automated planimetry using ImageJ soft-
ware (National Institutes of Health) and calculated as the ratio 
of infarct weight to total weight.
Echocardiography
Transthoracic echocardiography was performed at differ-
ent time points after surgery using an echocardiograph 
(Vevo2100). The investigator was blinded to group assign-
ment. Mice were anesthetized by isoflurane inhalation. 
Two-dimensional parasternal long axis views of the left ven-
tricle were obtained for guided M-mode measurements of 
the left ventricle internal diameter at the diastole end and the 
systole end, as well as the interventricular septal wall thickness 
and posterior wall thickness.
Flow cytometry and immunofluorescence
Flow cytometry and cell populations sorting were performed 
on a FAC SAria flow cytometer (BD), using a range of anti-
bodies. Flow cytometry data were analyzed using FlowJo (v.9 
or v.10; Tree Star). Confocal microscopy was used to image 
immunofluorescence using a range of antibodies and quanti-
fied using ImageJ software.
Reconstitution of mouse DP1
The mouse DP1 cDNA was subcloned into pcDNA3.1, 
and a HA tag was added at the extracellular N termi-
nus. Peritoneal macrophages from DP1−/− mice were 
transiently transfected with pcDNA3.1/DP1 plasmid or 
pcDNA3.1 empty vector using PT-103-01N jetPEI-Mac-
rophage reagent (PolyPlus-transfection), according to the 
manufacturer’s protocol.
PG extraction and analysis
500 µl of cell supernatant or peritoneal exudates was used for 
PG extraction after protein quantification. 2 µl of an internal 
standard was added to the sample in 40 µl of 1 M citric acid 
and 5 µl of 10% butylated hydroxytoluene, and the sample was 
strenuously vibrated with 1 ml solvent (normal hexane/ethyl 
acetate, 1:1) for 1 min. The organic phase supernatant was 
collected after centrifugation at 6,000 g/min for 10 min The 
eluate was dried under nitrogen and analyzed by electrospray 
triple/quadruple liquid chromatography (LC) coupled with 
tandem mass spectrometry (MS/MS; 4000Q Trap AB; Sciex). 
Chromatographic separation was performed on ZOR BAX 
SB-Aq HPLC columns (3 × 250 mm, 5 µm; Agilent Technol-
ogies), using 0.1% acetic acid in water (mobile phase A) and 
Figure 10. Effect of Prkar1a knockdown on BW254C-induced 
M2 macrophage polarization. (A) Efficiency of Prkar1a knockdown in 
macrophages. **, P < 0.01 versus scramble. n = 4. (B–G) Effect of Prkar1a 
knockdown on proinflammatory (B–D) and antiinflammatory (E–G) gene 
expression in BW-pretreated macrophages. *, P < 0.05; **, P < 0.01 versus 
vehicle. n = 4–6. All graphs are shown as mean ± SEM. Data are represen-
tative of two independent experiments. Statistical significance was deter-
mined using unpaired Student's t tests.
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acetonitrile (mobile phase B) as the mobile phase for binary 
gradient elution. The column flow rate was 0.4 mL/min, the 
column temperature was 25°C, and the autosampler was kept 
at 4°C. The binary elution gradient was 30% B to 53% B in 
15 min and then was to 90% B in 1 min, maintained at 90% 
B for 3 min. The column was equilibrated for 10 min with 
the initial solvent composition between injections. PGD2 was 
detected and quantified in negative ion mode, and the elec-
trospray potential was maintained at −4.5 kV and heated to 
500°C. For MS/MS analysis, PGD2/internal standards were 
subjected to collision-induced fragmentation. PG production 
was normalized to total protein or per mouse.
Immunofluorescence staining
Primary and sorted macrophages were plated on coverslips, 
washed twice with PBS, fixed in 4% formaldehyde for 30 
min at room temperature, and then washed three times with 
PBS. Cells were blocked with 3% bovine serum albumin and 
permeabilized with 0.1% Triton X-100 in PBS for 30 min 
at room temperature before incubating with rat anti–mouse 
CD68 antibody (1:400) and rabbit anti–mouse NOS2 (1:500) 
antibody or rabbit anti–mouse IFN-γR2 (1:200) antibody 
and mouse anti–mouse PRK AR2A (1:200) antibody at 4°C 
for 18–20 h. Cells were washed and incubated with appropri-
ate secondary antibody (1:1,000) for 2 h at room temperature 
and then rinsed in PBS, counter-stained with DAPI, sealed 
with antifade reagent, and visualized using a laser scanning 
confocal microscope (Olympus). Images were analyzed with 
ImagePro Plus software (Media Cybernetics).
Measurement of cellular cAMP Levels
Cells were washed with cold PBS and then harvested in ice-
cold lysis buffer. The amount of intracellular cAMP was de-
termined using a cAMP Parameter Assay kit (R&D Systems), 
according to the manufacturer’s instructions.
RNA extraction and qRT-PCR
Total RNA samples from sorted cells or adherent macro-
phages were prepared using an RNeasy Mini kit (QIA GEN) 
or TRIzol reagent (Invitrogen), according to the manufactur-
er’s instructions. Total RNA (1 µg) was reverse-transcribed to 
cDNA with a Reverse Transcription Reagent kit (Takara Bio 
Inc.), according to the manufacturer’s instructions. The result-
ing cDNA was amplified for 40 cycles. L32 and GAP DH 
RNA were amplified as internal controls. Each sample was 
analyzed in triplicate and normalized to a reference RNA. 
PCR products were confirmed by a single band of expected 
size on a 2% agarose gel. The primer sequences for PCR are 
summarized in Table S1.
Western blotting
The protein concentrations of adherent or sorted macrophage 
lysates were determined using a bicinchoninic acid assay pro-
tein assay kit (Thermo Fisher Scientific). Equal quantities of 
proteins were denatured and resolved by 10% SDS-PAGE 
gels, transferred to nitrocellulose membranes, incubated with 
5% skimmed milk for 1–1.5 h, and then incubated with pri-
mary antibodies overnight at 4°C. Primary antibodies were 
diluted as follows: COX-1 (1:1,000; Cayman Chemical), 
COX-2 (1:1,000; Cayman Chemical), DP1 (1:200; Cay-
man Chemical), HA-tag (1:1,000; Cell Signaling Technol-
ogy), phospho-JAK1 (1:1,000; Cell Signaling Technology), 
JAK1 (1:1,000; Cell Signaling Technology), phospho-JAK2 
(1:1,000; Cell Signaling Technology), JAK2 (1:1,000; AB-
clonal), phospho-JAK3 (1:1,000; Cell Signaling Technology), 
JAK3 (1:1,000; Cell Signaling Technology), phospho-STAT1 
(1:1,000; Cell Signaling Technology), STAT1 (1:1,000; AB-
clonal), phospho-STAT6 (pY641) (1:1,000; BD), STAT6 
(1:1,000; ABclonal), Ym1 (1:1,000; R&D Systems), NOS2 
(1:500; Abcam), FLAG M2 (1:2,000; ABclonal), His-tag 
(1:2,000; Cell Signaling Technology), glutathione S-transfer-
ase (GST)–tag (1:2,000; ABclonal), IFN-γR2 (1:500; Santa 
Cruz Biotechnology, Inc.), and PRK AR2A (1:500; Santa 
Cruz Biotechnology, Inc.). Actin (1:2,000; Sigma-Aldrich) 
or GAP DH (1:2,000; Cell Signaling Technology) was used 
as the load control. The membranes were then incubated in 
HRP-labeled secondary antibody in blocking buffer for 2 h at 
room temperature. Blots were developed using an enhanced 
chemiluminescence reagent (Thermo Fisher Scientific).
Micro–LC-MS/MS protein preparation
Peritoneal macrophage, RAW264.7, or 293T cells transfected 
with mock or FLAG-tagged IFN-γR2 and HA-tagged PRK 
AR2A were cultured in the presence of LPS/IFN-γ and 
BW245C. Protein extracts were then incubated with anti–
IFN-γR2, followed by anti-FLAG M2 beads or anti-HA 
beads. Samples were separated by 10% SDS-PAGE, the gels 
were subjected to silver staining, and then bands of interest 
were excised for further micro–LC-MS/MS analysis.
Immunoprecipitation
Cell lysates were incubated with the indicated antibodies for 
12 h followed by protein A/G beads for another 3 h. Beads 
were washed three times and eluted with SDS loading buf-
fer. Native PAGE analysis was performed as described in the 
Western blotting section..
Recombinant protein expression and purification
BL21 E. coli cells were transformed with the expression 
plasmids pGEX-4T-2–IFN-γR2, pGEX-4T-2-TMR, pET-
28a-PRK AR2A, and pET-28a-PBC. Recombinant proteins 
were purified using GST-Bind agarose (ELP IS Biotech) or 
Ni–nitrilotriacetic acid agarose (QIA GEN) resin according 
to manufacturer’s protocol.
RNA interference
Peritoneal macrophages were grown to ∼80% confluence for 
siRNA transfection by RNAiFect Transfection reagent (QIA 
GEN) according to the manufacturer’s instructions with ei-
ther a siRNA pool (Genepharma) containing three pairs of 
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specific sequences for prkar1a (100 nmol/L), prkar1a splice 
variant targeting sequences, or a scrambled siRNA (as a neg-
ative control; 100 nmol/L). The mouse prkar1a siRNAs were 
designed to target 21-nucleotide sequences. Control siR-
NAs included scrambled derivatives of the prkar1a siRNA 
sequences, an unrelated siRNA labeled by FAM, and a posi-
tive control GAP DH siRNA. In brief, knockdown efficiency 
was assessed by qRT-PCR (si-prkar1a-FGCG AAA GAG GAA 
GAU GUA UTTsi-prkar1a-RAUA CAU CUU CCU CUU 
UCG CTT). 1 µg siRNA and RNAiFect Transfection reagent 
were mixed and incubated for 10–15 min at room tempera-
ture to allow formation of transfection complexes before de-
livery on the cells. 48–72 h after interference, the cells were 
treated for further experiments.
Statistical analysis
All data are expressed as the mean ± SEM. Data were analyzed 
in Prism 5 (GraphPad Software). Two-tailed Student’s t test-
ing and ANO VA were used for comparisons between differ-
ent groups. Survival rates were compared using the log-rank 
test. P-values <0.05 were considered statistically significant.
Online supplemental material
Fig. S1 shows the generation and characterization of myeloid 
cell–specific DP1-deficient mice. Fig. S2 shows the generation 
of Mac-DP1-Tg mice. Table S1 lists the primers used for 
quantitative PCR. Online supplemental material is available at 
http ://www .jem .org /cgi /content /full /jem .20160459 /DC1.
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